![](https://ml.globenewswire.com/media/09e35daa-517c-4cec-993c-245317935107/small/rm-primary-logo-humble-png.png)
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
REDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its financial results for the quarter …